Angelman syndrome and thyroid dysfunction.

Area of Science:

• Neurogenetics
• Endocrinology
• Pediatrics

Background:

• Angelman syndrome (AS) is a rare neurogenetic disorder caused by genetic alterations in the maternal imprinting gene UBE3A.
• The prevalence of AS ranges from 1:10,000 to 1:40,000, with diagnosis confirmed by molecular evaluations.
• Thyroid dysfunction has not been previously described as a clinical feature of Angelman syndrome.

Observation:

• This report presents a novel case of a patient diagnosed with Angelman syndrome.
• The patient also exhibited subclinical hypothyroidism (SCH) without the presence of a goiter.
• This co-occurrence suggests a potential, yet unelucidated, link between AS and thyroid abnormalities.

Findings:

• The study identifies a case of Angelman syndrome co-occurring with subclinical hypothyroidism.
• Molecular confirmation of AS was established through genetic analysis of the UBE3A gene.
• The absence of goiter in the presence of SCH in this AS patient is a notable clinical observation.

Implications:

• This case highlights a potential association between Angelman syndrome and thyroid dysfunction, specifically subclinical hypothyroidism.
• Further research is warranted to investigate the underlying pathogenic mechanisms connecting the UBE3A gene and thyroid function.
• Understanding this relationship may lead to improved diagnostic and management strategies for patients with Angelman syndrome.